CD274 and neoplasm: Expression of PD-L1 on tumor cells and tumor-infiltrating inflammatory cells within tumor tissues and on inflammatory cells within non-tumor normal tissues were detected in 1 (13%), 7 (88%), and 4 (50%) of 8 recurrence-free patients before BCG therapy, respectively (Table 5).